Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Tissue Regenix Group (TRX) Share News

IN BRIEF: Tissue Regenix eyes profit beat; plots German jv disposal

31st Jan 2025 21:30

Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - Revenue increases 8% to USD28.4 million in the year ending December 31 from USD26.3 million a year prior. In addition, expects to report an adjusted earnings before interest, tax, depreciation and amortisation above expectations. Notes this will mark the second full year of profitability for Tissue Regenix and the fourth year of above-market growth. Read More

IN BRIEF: Tissue Regenix contacts firms as it considers possible sale

4th Nov 2024 18:21

Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - In response to press reports, say that it is conducting a review of strategic options, which may include soliciting offers for Tissue Regenix. Accordingly, the firm has contacted a limited number of potential counterparties to assess whether they could put forward a proposal "that would deliver greater value to Tissue Regenix's shareholders than pursuing a standalone independent strategy". Says it has not received any indicative non-binding proposals to date, and says there can be no certainty any offer will be made. Read More

EARNINGS AND TRADING: Blackbird loss narrows; Futura Medical in profit

10th Sep 2024 21:21

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

3rd Sep 2024 11:31

IN BRIEF: Tissue Regenix eyes revenue and adjusted profit growth

16th Jul 2024 11:30

Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - Says trading in the first half of 2024 was strong, as it expects revenue to have climbed 16% to USD16.4 million from USD14.1 million a year prior. "The BioRinse segment continued to deliver solid growth driven by increased efficiencies, while the commercial reorganisation of the dCELL segment continued to show benefits, demonstrating robust growth within the period," Tissue Regenix says. It will report its full half-year results on September 10. Read More

Tissue Regenix purchases Texas facility to generate cost savings

14th Jun 2024 14:36

(Alliance News) - Tissue Regenix Group PLC on Friday said it purchased an existing facility as part of phase 1 and 2 expansion plans. Read More

UK shareholder meetings calendar - next 7 days

18th Apr 2024 14:12

Tissue Regenix annual loss narrows sharply as revenue jumps

19th Mar 2024 14:24

(Alliance News) - Tissue Regenix Group PLC on Tuesday said it was aiming for longer-term growth as it reported a sharp reduction in its annual losses. Read More

UK earnings, trading statements calendar - next 7 days

12th Mar 2024 14:29

IN BRIEF: Tissue Regenix ships first allograft products order

6th Feb 2024 10:42

Tissue Regenix Group PLC - Leeds, England-based medical devices - First order of its allograft products has been shipped from its third-party Irish logistics hub Biostor Ireland Ltd, following approval from the Irish Health Products Regulatory Authority in October. The logistics hub provides a central European location for the distribution of its allograft products throughout the EU, "facilitating increased shipments across the EU and aiding the potential for further partnerships and distributor contracts within these countries". Read More

TRADING UPDATES: Treatt revenue falls; Secure Trust profit picks up

25th Jan 2024 20:21

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

TRADING UPDATES: Solid State expects higher annual revenue

30th Oct 2023 14:31

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

Tissue Regenix loss narrows on higher revenue; launches BioRinse

5th Sep 2023 11:50

(Alliance News) - Tissue Regenix Group PLC on Tuesday reported double-digit topline growth in the first half of 2023, as it announced the launch of a product line. Read More

UK earnings, trading statements calendar - next 7 days

29th Aug 2023 15:45

TRADING UPDATES: Beacon sees delays; Churchill China trades in line

17th Jul 2023 15:49

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

Tissue Regenix signs exclusive distribution deal with Joint Operations

10th Jul 2023 11:37

(Alliance News) - Tissue Regenix said on Monday that it had signed an exclusive distribution agreement with Joint Operations Ltd to distribute the Tissue Regenix OrthoPure XT product in the UK. Read More

IN BRIEF: Tissue Regenix signs multi-year distribution contract

25th May 2023 10:45

Tissue Regenix Group PLC - Leeds, England-headquartered regenerative medical device company - Announces signing of exclusive three-year distribution agreement with Australian Allografts, which collects and distributes Australian donated tissue, for an undisclosed sum. Agreement is subject to regulatory approval from the Australian government's Therapeutic Goods Administration. It allows for the distribution of Tissue Regenix's OrthoPure XT product in Australia and New Zealand. OrthoPure XT is a decellularised xenograft ligament used in knee ligament reconstruction procedures. It utilises the company's patented dCELL technology. Read More

IN BRIEF: Surgical Innovations says Glenn becomes chair later this year

22nd May 2023 12:25

Surgical Innovations Group PLC - Leeds, England-based surgical & medical instrument manufacturer - Names Jonathan Glenn as senior independent non-executive director and chair-designate with immediate effect. Says Glenn has track record in the medical device sector. He currently is non-executive chair of medical device company Tissue Regenix PLC and formerly was chief executive officer of drug delivery devices supplier Consort Medical PLC from 2007 to 2020. Says Glenn will succeed Nigel Rogers as chair upon announcement of interim results in September. Read More

TRADING UPDATES: FireAngel signs two delivery and production deals

18th Apr 2023 18:49

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Tissue Regenix reports narrowed loss and higher revenue

21st Mar 2023 12:37

Tissue Regenix Group PLC - Leeds, England-based medical device company - Reports revenue of USD24.5 million for 2022, up 24% from USD19.7 million a year earlier. Particularly, BioRinse increased by 26% to USD16.0 million from USD12.7 million. Pretax loss narrows to USD2.8 million from USD5.1 million in 2021, as operating loss narrows to USD2.0 million from USD4.4 million. Declares no dividend for the year, unchanged from a year prior. Looking ahead, Tissue Regenix says it is well prepared for additional market fluctuations as markets continue to normalise post-pandemic. Read More

FTSE 100 Latest

Value8,809.74

Change53.53